Head of Securities Compliance
MercuryFull Time
Expert & Leadership (9+ years)
Jersey City, New Jersey, United States
Key technologies and capabilities for this role
Common questions about this position
The role requires a minimum of 3 days a week of onsite presence (or more as business needs require) in the Jersey City (NJ) office to ensure effective management, operational excellence, and collaboration.
The role requires in-depth knowledge of FDA and international regulatory requirements, exceptional communication, negotiation, and project management skills, plus strong analytical skills, attention to detail, problem-solving, and adaptability.
The company emphasizes a collaborative, cross-functional team environment, with a focus on thriving in teamwork, regulatory integrity, transparency, and supporting team growth.
A strong candidate is a seasoned regulatory professional with proven experience developing and executing regulatory strategies, managing submissions like INDs and NDAs, ensuring compliance, and fostering cross-functional collaboration while liaising with agencies.
This information is not specified in the job description.
Biotech startup developing innovative medicines
Eikon Therapeutics focuses on discovering and developing new medicines in the pharmaceutical industry. The company employs advanced technologies to study biological systems, aiming to identify new drug targets by examining the dynamic aspects of biology rather than just static chemical processes. Their team consists of diverse professionals, including data scientists, chemists, and engineers, which allows them to combine science and engineering to create new therapies that aim to improve and extend life. A key feature of Eikon's approach is their proprietary single-molecule tracking (SMT) platform, which enables rapid visualization of protein movements in living cells. This technology, along with artificial intelligence and automation, allows for precise inventorying of molecular interactions. Eikon Therapeutics targets patients with serious diseases who need effective treatments, generating revenue through the development and commercialization of their therapies.